Medicine
Kapspargo 200 mg extended-release capsule
Kapspargo 200 mg extended-release capsule is a prescription medicine containing Metoprolol for oral use, marketed by Sun Pharmaceutical Industries, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° C - 25° C (68° F - 77° F).
Key facts
- Active ingredient (INN)
- Metoprolol
- Brand
- Kapspargo
- Strength
- 200 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 30 capsules
- Marketing authorisation holder
- Sun Pharmaceutical Industries
- Manufacturer
- Sun Pharmaceutical IndustriesIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20° C - 25° C (68° F - 77° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 March 2018
- Identifiers
- RxCUI 1999031, 1999033, 1999035 +5DailyMed set ID 9cfa55b4-15c6-40f7-b6e5-41096ee51bfcNDC 10631-011Application NDA210428
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule, extended release in 1 bottle | 10631-011-30 | Sun Pharmaceutical IndustriesIndia | 15 March 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 August 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Metoprolol 200 mg extended-release capsule.
Other strengths and forms of Metoprolol
Clinical summary
Metoprolol is a beta-adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. It is available as extended-release tablets, tablets and injection for oral and intravenous use. MedsAcross supplies Metoprolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MetoprololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lopressor prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Kapspargo 200 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.